EYES

Second Sight Medical Products Inc
4.14
0.00 (0.0%)

Vivani Medical Inc. Com (EYES) Fundamentals

Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.
SHARE INFORMATION
Market Cap$ 54,384,659
Shares Outstanding13,136,391
Float9,363,237
Percent Float71.28%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.84
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions61
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months98,617
Institutional Holdings Percent12.5%
Institutional Sold Previous 3 Months535,258
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months542,851
Insider Holdings Percent1.6
Insider Sold Previous 3 Months-
Insider Shares Owned611,942
TRADING INFO
52 Week High$ 12.72
52 Week Low$ 3.42
52 Week High Change$ -62.70
21 Day Moving Average$ 5.3105
21 Day Extended Moving Average$ 5.0457
50 Day Moving Average$ 5.8424
50 Day Extended Moving Average$ 5.4891
200 Day Moving Average$ 5.2162
200 Day Extended Moving Average$ 6.1974
10 Day Average Volume112,127
20 Day Average Volume113,015
30 Day Average Volume90,114
50 Day Average Volume76,711
Alpha0.016079
Beta2.5564
Standard Deviation0.544360
R20.055169
7 Day Price Change$ 0.03
7 Day Percent Change0.73%
21 Day Price Change$ -1.74
21 Day Percent Change-29.59%
30 Day Price Change$ -1.26
30 Day Percent Change-23.33%
Month to Date Price Change$ -1.26
Month to Date Percent Change-23.33%
Quarter to Date Price Change$ -1.95
Quarter to Date Percent Change-32.02%
180 Day Price Change$ 0.21
180 Day Percent Change5.34%
200 Day Price Change$ 0.12
200 Day Percent Change2.99%
Year to Date Price Change$ -0.75
Year to Date Percent Change-15.34%

Vivani Medical Inc. Com (EYES) Key Ratios

PROFITABILITY
EBIT Margin-3,915.3%
EBITDA Margin-3,864.6%
Pre-Tax Profit Margin-973.2%
Profit Margin Count0.0%
Gross Margin75.1%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.90
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio22.10
Leverage Ratio1.00
Quick Ratio21.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-6.80
Enterprise Value$ 2,493,667
Price to Sales0.00
Price to Free Cash-6.20
PE High Last 5 Years-0.30
Price To Book0.90
Price To Cash Flow0.00
PE Low Last 5 Years-1.70
Price to Tangible Book0.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover-1.00
Assets Turnover0.00
Return Assets-13.67
Return on Equity-14.31
Return on Capital-13.38

Vivani Medical Inc. Com (EYES) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorGumbiner Savett Inc.
CEOScott Dunbar
Emplyoees15
Last AuditUQ
CIK0001266806
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSSurgical and Medical Instrument Manufacturing(339112)
CONTACT INFO
Address13170 Telfair Avenue
Suite 400
Sylmar, CA 91342
Websitehttps://www.secondsight.com
Facsimile+1 818 833-5067
Telephone+1 818 833-5000
Emaillwilson@insitecony.com


Your Recent History
NASDAQ
EYES
Second Sig..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.